Tag: Prescription Drugs
Program in Peds Rheumatology Clinic Ups Education on Teratogenic Rx
Findings seen among girls, women of childbearing age prescribed teratogenic meds
Multidimensional Approach Cuts Unneeded Drug-Drug Interaction Alerts
Number of interruptive DDI alerts substantially decreased as result of alert refinement efforts
AAD: Isotretinoin Exposure for Acne Not Linked to Depression Risk
Acne patients with, without isotretinoin exposure had no significant difference in depression frequency
FDA Warns Americans Not to Buy Drugs From Canadian Company
CanaRx sells prescription medicines at a lower cost to U.S. public, private employer programs
FDA: Pulmonary Embolism Risk Up With Tofacitinib 10 mg for RA
Safety clinical trial shows risk for PE, death with 10-mg dose versus 5-mg dose, TNF inhibitor
Tumor Control Durable With Pembrolizumab in Merkel Cell Cancer
28 of 50 advanced MCC patients responded; 24-month overall survival rate was 68.7 percent
Stewardship Programs Decrease Inpatient Fluoroquinolone Rx
Interventions tied to less prescribing in hospital but did not impact fluoroquinolone discharge treatment
Lowering BP, Lipids in Healthy Elderly Has No Cognitive Effect
Candesartan/hydrochlorothiazide, rosuvastatin, combination therapy do not affect cognitive decline
CDC: Progress in HIV Prevention Has Stalled in the United States
Agency says effective HIV prevention, treatment not reaching those who could most benefit
Converting Naloxone to OTC Expected to Increase Sales
Demand for naloxone is inelastic, with 1 percent increase in price resulting in 0.27 percent drop in sales
